Cyproheptadine-Prazosin Combination for AUD
April 24, 2024
A recent double-blind, parallel group, placebo-controlled Phase 2 c...
Read More
TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Positive Phase 3 Topline Results Evaluating Lumateperone as Adjunctive Therapy for MDD
April 22, 2024
Encouraging results from a Phase 3 clinical trial evaluating lumate...
Read More
Highlights from 2024 NEI Synapse: We Didn’t Write the Rx: A Guide to the Pros and Cons of Complementary and Alternative Medicine
April 21, 2024
Complementary health approaches are commonly used by patients seeki...
Read More
Highlights from 2024 NEI Synapse: Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan
April 20, 2024
One of the most overlooked and underdiagnosed manifestations along ...
Read More
Highlights from 2024 NEI Synapse: The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression
April 19, 2024
Major depressive disorder (MDD) can be difficult to treat and if pa...
Read More
Highlights from 2024 NEI Synapse: Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease
April 18, 2024
In her 2024 NEI Synapse presentation, Dr. Dani Cabral enlightened t...
Read More
Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
Metabolic Markers Tied to Increased Risk of Mental Disorders
April 6, 2024
A recent study examined whether the biomarkers of carbohydrate, lip...
Read More
FDA Approves Treatment for Mixed, Manic Episodes Associated With Bipolar I Disorder
April 3, 2024
The FDA has expanded the approval iloperidone to include for the ac...
Read More
Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia
April 2, 2024
In a recent study examined the efficacy of various treatments for a...
Read More
FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD
April 1, 2024
The FDA has cleared the first prescription digital therapeutic auth...
Read More